Apogee Therapeutics (APGE) Shares Issued (2023 - 2026)

Apogee Therapeutics (APGE) has 4 years of Shares Issued data on file, last reported at $378.2 million in Q1 2026.

• Quarterly Shares Issued rose 60698.87% year-over-year to $378.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $465.1 million (up 934.1% YoY) and the FY2025 annual result came in at $67.6 million, down 84.98% from the prior year.
• Shares Issued advanced to $378.2 million in Q1 2026 per APGE's latest filing, from $67.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $450.5 million in Q1 2024 and bottomed at -$622000.0 in Q2 2025.
• The 4-year median for Shares Issued is $20.0 million (2025), against an average of $106.7 million.
• The widest annual swing landed in 2025, when Shares Issued plunged 99.86%; it then soared 60698.87% in 2026.
• Tracing APGE's Shares Issued over 4 years: stood at -$213000.0 in 2023, then jumped by 21179.81% to $44.9 million in 2024, then surged by 50.56% to $67.6 million in 2025, then surged by 459.42% to $378.2 million in 2026.
• Per Business Quant, the three latest APGE Shares Issued figures stand at $378.2 million (Q1 2026), $67.6 million (Q4 2025), and $20.0 million (Q3 2025).

Peer Comparison